For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.

Imagine this: You walk into your doctor and get your yearly flu vaccine and a yearly dose of your weight-loss ... prescribed for diabetes, and Zepbound, for obesity. If you ask him what he's ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as effective as bariatric surgery.

Another drug, Zepbound ... liquid solution in a single-use prefilled pen. You’ll inject Mounjaro under your skin once weekly. You can take your dose with or without food. Mounjaro can be ...